ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Teva, Modag to develop drug candidates for neurodegenerative disease
October 29, 2021Teva Pharmaceutical has partnered with Modag for the development and licensing of the latter’s drug candidates, anle138b and sery433, for neurodegenerative disease. -
MODAG initiates first-in-patient phase 1b trial for Anle138b in Parkinson´s Disease
December 31, 2020MODAG announced the clinical trial initiation of a first-in-patient Phase 1b study for anle138b in patients with mild to moderate Parkinson´s Disease (PD).
Pharma Sources Insight January 2025
